TY  - JOUR 
AU  - Zarzuelo Romero, María José
AU  - Carrasco Campos, María Isabel
AU  - Sánchez Martín, Almudena
AU  - Ramírez Tortosa, María Carmen
AU  - Jiménez Morales, Alberto
PY  - 2021
UR  - http://hdl.handle.net/10481/69121
AB  - The introduction of new therapies for the treatment of multiple sclerosis (MS) is a very recent phenomenon and little is known of their mechanism of action. Moreover, the response is subject to interindividual variability and may be affected by...
LA  - eng
PB  - MDPI
KW  - Multiple sclerosis
KW  - Natalizumab
KW  - Fingolimod
KW  - Teriflunomide
KW  - Dimethyl fumarate
KW  - Alemtuzumab
KW  - Cladribine
KW  - Siponimod
KW  - Ocrelizumab
KW  - Response
KW  - Polymorphisms
TI  - Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis
DO  - 10.3390/jpm11050335
ER  -